High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

Item
http://www.wikidata.org/entity/Q35900929
PR1-specific T cells are associated with unmaintained cytogenetic remission of chronic myelogenous leukemia after interferon withdrawal.Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein.Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic miceThe role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1.Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune responseHematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy.Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibLeukemia-associated antigens as target structures for a specific immunotherapy in chronic myeloid leukemia.Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.The lost intrinsic fragmentation of MAT1 protein during granulopoiesis promotes the growth and metastasis of leukemic myeloblasts.PR1 vaccination in myeloid malignancies.Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.The bone marrow stroma in hematological neoplasms--a guilty bystander.Antigens in chronic myeloid leukemia: implications for vaccine development.Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells.
P2860

High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

Item
http://www.wikidata.org/entity/Q35900929
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
High PR3 or ELA2 expression by ...... graft-versus-leukemia effects.
@ast
High PR3 or ELA2 expression by ...... graft-versus-leukemia effects.
@en
type
label
High PR3 or ELA2 expression by ...... graft-versus-leukemia effects.
@ast
High PR3 or ELA2 expression by ...... graft-versus-leukemia effects.
@en
prefLabel
High PR3 or ELA2 expression by ...... graft-versus-leukemia effects.
@ast
High PR3 or ELA2 expression by ...... graft-versus-leukemia effects.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
High PR3 or ELA2 expression by ...... graft-versus-leukemia effects
@en
P2093
P2860
P304
P31
P356
10.1182/BLOOD-2007-02-071738
P407
P433
P478
P50
P577
P5875
P698
P921
P932